welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Sulindac/Erlotinib Combo Tested in Patients with Familial Adenomatous Polyposis
A lower duodenal polyp burden was seen after 6 months of treatment with sulindac and erlotinib vs. placebo among patients with familial adenomatous polyposis (FAP), a study published in JAMA reports.
expertly curated content related to this topic
-
Proctocolectomy for Colorectal Cancer–Is the Ileal Pouch Anal Anastomosis a Safe Alternative to Permanent Ileo...PURPOSE : Ileal pouch anal anastomosis (...
-
Anorectal Functional Outcome After Repeated Transanal Endoscopic MicrosurgeryAIM : To evaluate the status of anorecta...
-
Role of Surgery in Familial Adenomatous Polyposis and Hereditary Non Polyposis Colorectal Cancer (Lynch Syndrome)Surgery remains the mainstay of treatmen...
-
Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysisObjective The benefits of pancreatic ...
-
The Traveling J-Pouch: More Tips for Going Abroad with a J-Pouchhttps://www.youtube.com/watch?v=Vk5AmBLF...
-
Appropriate Use of Endoscopy in the Diagnosis and Treatment of Gastrointestinal Diseases: Up-to-date Indications for...The field of endoscopy has revolutionize...